Skip to main content

Advertisement

ADVERTISEMENT

Department

Conference Insider
08/30/2018
A recent study examined the US Preventive Services Task Force (USPSTF) accepted colorectal cancer screening modalities and found that adding two additional screening tests to the current guidelines did not significantly influence the overall...
A recent study examined the US Preventive Services Task Force (USPSTF) accepted colorectal cancer screening modalities and found that adding two additional screening tests to the current guidelines did not significantly influence the overall...
A recent study examined the US...
08/30/2018
First Report Managed Care
Conference Insider
08/30/2018
In a recent study presented at Digestive Disease Week 2018, researchers found a wide variation in 30-day readmission rates among hospitals for acute pancreatitis.
In a recent study presented at Digestive Disease Week 2018, researchers found a wide variation in 30-day readmission rates among hospitals for acute pancreatitis.
In a recent study presented at...
08/30/2018
First Report Managed Care
Conference Insider
08/30/2018
A pharmacist-led proactive therapeutic drug-monitoring program for patients taking Remicade (infliximab; Janssen) reduced costs and improved dose utility, according to research presented at Digestive Disease Week 2018.
A pharmacist-led proactive therapeutic drug-monitoring program for patients taking Remicade (infliximab; Janssen) reduced costs and improved dose utility, according to research presented at Digestive Disease Week 2018.
A pharmacist-led proactive...
08/30/2018
First Report Managed Care

Advertisement

Conference Insider
08/30/2018
According to a presentation at Digestive Disease Week 2018, use of intermittent intravenous proton pump inhibitors among patients with upper gastrointestinal bleeding was significantly cost-saving compared with continuous therapy. 
According to a presentation at Digestive Disease Week 2018, use of intermittent intravenous proton pump inhibitors among patients with upper gastrointestinal bleeding was significantly cost-saving compared with continuous therapy. 
According to a presentation at...
08/30/2018
First Report Managed Care
Conference Insider
08/30/2018
Patients often report cost-related insulin underuse that is commonly associated with poor glycemic control, according to research presented at the 2018 78th ADA Scientific Sessions. 
Patients often report cost-related insulin underuse that is commonly associated with poor glycemic control, according to research presented at the 2018 78th ADA Scientific Sessions. 
Patients often report...
08/30/2018
First Report Managed Care
Conference Insider
08/30/2018
In accordance with the American Diabetes Association (ADA) recommendations, researchers recently found that flash continuous glucose monitoring improved adherence and reduced acquisition costs when compared with self-monitoring of blood...
In accordance with the American Diabetes Association (ADA) recommendations, researchers recently found that flash continuous glucose monitoring improved adherence and reduced acquisition costs when compared with self-monitoring of blood...
In accordance with the American...
08/30/2018
First Report Managed Care

Advertisement

Conference Insider
08/30/2018
A recent systematic review, which was presented at the 2018 78th ADA Scientific Sessions, provided critical information for making evidence-based clinical and public health policy decisions.
A recent systematic review, which was presented at the 2018 78th ADA Scientific Sessions, provided critical information for making evidence-based clinical and public health policy decisions.
A recent systematic review,...
08/30/2018
First Report Managed Care
Conference Insider
08/30/2018
According to recent research, given the volatility in 340B and wholesale acquisition cost (WAC) pricing, a strategy for purchasing the most cost-effective national drug code (NDC) is complex and requires visibility to system purchase volume...
According to recent research, given the volatility in 340B and wholesale acquisition cost (WAC) pricing, a strategy for purchasing the most cost-effective national drug code (NDC) is complex and requires visibility to system purchase volume...
According to recent research,...
08/30/2018
First Report Managed Care
Conference Insider
08/30/2018
Inpatient administration of the cholesterol medication Zetia (ezetimibe; Merck) may be clinically warranted for only a small group of patients who are unresponsive or intolerant to statin therapy, according to research presented at the 2018...
Inpatient administration of the cholesterol medication Zetia (ezetimibe; Merck) may be clinically warranted for only a small group of patients who are unresponsive or intolerant to statin therapy, according to research presented at the 2018...
Inpatient administration of the...
08/30/2018
First Report Managed Care

Advertisement

Managed Care Q&A
07/20/2018
An interview with Russel J Spjut, PharmD, formulary management clinical pharmacist and consultant at Formulary Intel Consulting.
An interview with Russel J Spjut, PharmD, formulary management clinical pharmacist and consultant at Formulary Intel Consulting.
An interview with Russel J...
07/20/2018
First Report Managed Care

Advertisement